16.05.2005 19:01:00

Francis J. Lunger Elected DENTSPLY Director

Francis J. Lunger Elected DENTSPLY Director

To download high-resolution,
print-ready JPEG images,
click on the thumbnail image above.
WARNING: these images are
very large (800K+)
Click here for caption
To download high-resolution,
print-ready JPEG images,
click on the thumbnail image above.
WARNING: these images are
very large (800K+)
Click here for caption
To download high-resolution,
print-ready JPEG images,
click on the thumbnail image above.
WARNING: these images are
very large (800K+)
Click here for caption
To download high-resolution,
print-ready JPEG images,
click on the thumbnail image above.
WARNING: these images are
very large (800K+)
Click here for caption
To download high-resolution,
print-ready JPEG images,
click on the thumbnail image above.
WARNING: these images are
very large (800K+)
Click here for caption
Smart News Release Help

    Business Editors/Health/Medical Writers
    MULTIMEDIA AVAILABLE:
    http://www.businesswire.com/cgi-bin/mmg.cgi?eid=4886387

    YORK, Pa.--(BUSINESS WIRE)--May 16, 2005--DENTSPLY International Inc. (NASDAQ:XRAY) recently announced that Mr. Francis J. Lunger was elected as a new Director to the Company's Board with his initial term expiring at the conclusion of the 2008 Annual Meeting of Shareholders. This action increased the size of the DENTSPLY Board to 11 persons.
    Mr. Lunger was Chairman, President and Chief Executive Officer of Millipore Corporation (NYSE:MIL) from 2002 to 2004 and served on the company's Board of Directors from 2001 until March of this year. Headquartered in Billerica, MA, Millipore is a multinational, high technology bioscience company that provides technologies, tools and services for the development and production of new therapeutic drugs. Mr. Lunger joined Millipore in 1997 as Senior Vice President and Chief Financial Officer and held several executive management positions, which, in addition to the above, included serving as Executive Vice President and Chief Operating Officer from 2000 until 2001. Prior to joining Millipore, Mr. Lunger held executive management positions at Oak Industries, Inc., Nashua Corporation, and Raychem Corporation. He also serves on the Board of Trustees of the Landmark School in Pride's Crossing, MA.
    Mr. Gary K. Kunkle, Jr., Chairman and Chief Executive, said, "DENTSPLY is pleased to welcome a Director of Mr. Lunger's caliber to our Board and looks forward to his contributions to our continued success."
    DENTSPLY designs, develops, manufactures and markets a broad range of products for the dental market. The Company believes that it is the world's leading manufacturer and distributor of dental prosthetics, precious metal dental alloys, dental ceramics, endodontic instruments and materials, prophylaxis paste, dental sealants, ultrasonic scalers, and crown and bridge materials; the leading United States manufacturer and distributor of dental handpieces, dental x-ray film holders, film mounts and bone substitute/grafting materials; and a leading worldwide manufacturer or distributor of dental injectible anesthetics, impression materials, orthodontic appliances, dental cutting instruments and dental implants. The Company distributes its dental products in over 120 countries under some of the most well established brand names in the industry.
    DENTSPLY is committed to the development of innovative, high quality, cost-effective new products for the dental market.

MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=4886387

--30--RM/ph*

CONTACT: DENTSPLY International Inc. George Rhodes, 717-849-4273

KEYWORD: PENNSYLVANIA INDUSTRY KEYWORD: BANKING MEDICAL MANAGEMENT CHANGES PHOTO PHOTOWIRE SOURCE: DENTSPLY International Inc. PHOTO: 45480

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu DENTSPLY SIRONA Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

DENTSPLY SIRONA Inc 18,16 -0,19% DENTSPLY SIRONA Inc

Indizes in diesem Artikel

NASDAQ Comp. 20 109,06 -0,32%
NASDAQ 100 22 001,08 -0,43%
S&P 400 MidCap 1 854,40 -0,45%